Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
+$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 4 |
Johnson & Johnson
JNJ
|
+$256M |
| 5 |
Procter & Gamble
PG
|
+$170M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
NVIDIA
NVDA
|
+$471M |
| 3 |
X
US Steel
X
|
+$421M |
| 4 |
JPMorgan Chase
JPM
|
+$237M |
| 5 |
Deere & Co
DE
|
+$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Quanterix
QTRX
$210M
| $5.34M | ﹤0.01% |
803,735
-37,598
| -4% | -$250K |
|
2502
Companhia Siderúrgica Nacional
SID
$1.97B
| $5.32M | ﹤0.01% |
3,799,430
-221,161
| -6% | -$310K |
|
2503
GDS Holdings
GDS
$7.23B
| $5.32M | ﹤0.01% |
173,999
+23,948
| +16% | +$732K |
|
2504
American Coastal Insurance
ACIC
$533M
| $5.3M | ﹤0.01% |
476,521
+150,767
| +46% | +$1.68M |
|
2505
OptimizeRx
OPRX
$343M
| $5.19M | ﹤0.01% |
384,747
-47,314
| -11% | -$639K |
|
2506
Designer Brands
DBI
$227M
| $5.19M | ﹤0.01% |
2,179,446
-68,985
| -3% | -$164K |
|
2507
Innovative Solutions & Support
ISSC
$199M
| $5.18M | ﹤0.01% |
373,386
-43,594
| -10% | -$605K |
|
|
MGIC
2508
Magic Software Enterprises
MGIC
$1.01B
| $5.17M | ﹤0.01% |
270,708
+9,338
| +4% | +$178K |
|
2509
Forrester Research
FORR
$190M
| $5.16M | ﹤0.01% |
520,972
+9,549
| +2% | +$94.5K |
|
2510
CSP Inc
CSPI
$110M
| $5.16M | ﹤0.01% |
398,512
-21,814
| -5% | -$282K |
|
2511
Personalis
PSNL
$544M
| $5.15M | ﹤0.01% |
784,864
+149,835
| +24% | +$983K |
|
2512
Olema Pharmaceuticals
OLMA
$563M
| $5.14M | ﹤0.01% |
1,207,150
-112,029
| -8% | -$477K |
|
|
NOAH
2513
Noah Holdings
NOAH
$800M
| $5.11M | ﹤0.01% |
427,966
+18,935
| +5% | +$226K |
|
2514
Digital Turbine
APPS
$487M
| $5.11M | ﹤0.01% |
865,994
+244,112
| +39% | +$1.44M |
|
2515
Atea Pharmaceuticals
AVIR
$259M
| $5.08M | ﹤0.01% |
1,411,263
+227,537
| +19% | +$819K |
|
2516
OmniAb
OABI
$226M
| $5.07M | ﹤0.01% |
2,913,764
-217,954
| -7% | -$379K |
|
2517
Lindblad Expeditions
LIND
$755M
| $5.06M | ﹤0.01% |
433,293
+38,830
| +10% | +$453K |
|
2518
Crinetics Pharmaceuticals
CRNX
$3.16B
| $5.04M | ﹤0.01% |
175,257
+155,534
| +789% | +$4.47M |
|
2519
Iovance Biotherapeutics
IOVA
$861M
| $5.04M | ﹤0.01% |
2,928,736
-577,372
| -16% | -$993K |
|
2520
RxSight
RXST
$400M
| $5.02M | ﹤0.01% |
385,972
-5,691
| -1% | -$74K |
|
2521
Bank7 Corp
BSVN
$463M
| $4.97M | ﹤0.01% |
118,784
+11,889
| +11% | +$497K |
|
|
NAGE
2522
Niagen Bioscience, Inc. Common Stock
NAGE
$768M
| $4.94M | ﹤0.01% |
342,898
+161,799
| +89% | +$2.33M |
|
2523
Haleon
HLN
$44.2B
| $4.93M | ﹤0.01% |
475,703
-13,633
| -3% | -$141K |
|
2524
Farmers & Merchants Bancorp
FMAO
$357M
| $4.93M | ﹤0.01% |
195,078
+18,976
| +11% | +$480K |
|
2525
Talkspace
TALK
$434M
| $4.92M | ﹤0.01% |
1,769,519
+96,893
| +6% | +$269K |
|